Samsrita Labs (539267)
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹17.13 |
| Market Cap | ₹25.37 Cr |
| P/E Ratio | 0 |
| ROCE | -1.8% |
| ROE | -70.88% |
| Dividend Yield | 0% |
| Profit Growth | 0% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹13.78 — ₹25.27 |
| Sector | Healthcare Services |
| Book Value | ₹5.2 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
Dear investor, I look at Samsrita Labs and see a business that fails every test I apply. A healthcare service provider should earn meaningful returns on capital, but here ROE is -70.88% and ROCE is -1.80%. The latest quarter shows sales of zero and a net loss of ₹3 crore. You cannot value a company with no revenue and falling profitability; the trailing P/E is meaningless, and the stated P/B of 3.29 means the market prices this at ₹17.13 against book value of ₹5.20. That is a rich premium for a company destroying roughly 71% of equity each year.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer